Caris Life Sciences’ Post

Caris welcomes the University of Mississippi Medical Center (UMMC) to its extensive and expanding network of leading cancer institutions committed to improving patient outcomes through innovations in precision medicine. “UMMC’s commitment to cutting-edge therapy, clinical trials and interdisciplinary collaboration makes them a valuable Caris POA member. We’re eager to collaborate with their investigators on our shared mission of improving the outcomes of all patients affected by cancer,” said George Sledge, Jr., MD, EVP and Chief Medical Officer of Caris.” Learn more: https://lnkd.in/gSNarrna

Our best measure of success is the ability to help extend and improve the lives of cancer patients. Learn about the benefits of #molecularprofiling through our patient stories. https://lnkd.in/dFFX4-3t #precisionmedicine

Caris molecular testing can identify genetic errors, whether they are found in a patient's DNA, RNA, or proteins, to help oncologists recommend the best therapy options. Learn more: https://ow.ly/2Nl150SG3M9 #precisionmedicine #molecularprofiling #AI

Caris Assure is an advanced assay that analyzes over 23,000 genes at the DNA and RNA level, using whole exome and whole transcriptome sequencing. This approach offers exceptional accuracy and precision in evaluating crucial molecular features of a patient's cancer. Find out how Caris has transformed liquid biopsy profiling: https://lnkd.in/gZm92Zdg. #precisionmedicine #molecularprofiling

Caris is dedicated to helping improve the lives of as many people as possible. Our advanced profiling approach analyzes DNA, RNA, and proteins to better understand cancer at the molecular level. Learn more: http://ow.ly/8KFC50MgNNr

Check out the inside of our 66,000 sq. ft. tissue lab for an exclusive look at our cutting-edge molecular profiling facility. Discover how Caris's comprehensive molecular profiling can guide more personalized treatment decisions and improve patient outcomes: https://ow.ly/5l3Y50Sx5Fj

Unleash the potential of liquid biopsy with Caris Assure, an innovative multi-cancer assay that provides deep molecular insights from a simple blood sample. Explore how this powerful liquid biopsy assay can revolutionize patient care. Start ordering: https://lnkd.in/gZm92Zdg #molecularprofiling #precisionmedicine #liquidprofiling

Caris Life Sciences is committed to bringing awareness to sarcoma cancers. During Sarcoma Awareness Month, we are focused on educating individuals about the importance of molecular profiling in changing the course of treatment. Learn more about how Caris testing can make a difference: https://ow.ly/4jYE50StOrx #SarcomaAwarenessMonth

Following a great ASCO 2024, we spotlight Dr. George Sledge, Jr., former President of ASCO and current Caris Chief Medical Officer. In this feature, he shares his conference insights, his journey as an oncologist and how his passion for precision medicine led him to Caris. Learn More: https://lnkd.in/gGrtUEEB

Caris expands its extensive network of leading cancer institutions committed to improving patient outcomes through innovations in precision medicine by welcoming Mass General Cancer Center.   “We are thrilled to welcome Mass General Cancer Center, one of the world’s most respected centers, to the Caris Precision Oncology Alliance,” said George Sledge, Jr., MD, EVP and Chief Medical Officer of Caris. “We’re eager to work with their researchers and investigators on our shared mission of improving outcomes of all patients affected by cancer through precision oncology research.” Learn more: https://lnkd.in/ggni-zgg